Johnson & Johnson’s (J&J) nasal spray Spravato (esketamine) has received a label expansion, now approved as a monotherapy ...
In both Tonga and Samoa, the research found two percent could be diagnosed with depression. None of the people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback